Skip to main content

Advertisement

Log in

Adolescents with severe obesity show a higher cardiovascular (CV) risk than those with type 1 diabetes: a study with skin advanced glycation end products and intima media thickness evaluation

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 01 August 2020

Abstract

Aims

Type 1 diabetes (T1D) and obesity are strongly associated with cardiovascular (CV) risk and can start in the paediatric age. The CV risk profile of two groups of adolescents was compared through the evaluation of sAGE, IMT and known variables associated with CV risk. The first group was affected by T1D with duration of disease of at least 5 years or 3 years since puberty onset, and the second by severe obesity for more than 3 years.

Methods

A total of 116 patients were prospectively enrolled in the study (71 T1D, 33 males and 38 females; 45 obese, 18 males and 27 females), and their sAGE, IMT, waist/height ratio, LDL cholesterol, triglycerides/cholesterol HDL ratio, BMI, HbA1c and blood pressure were measured.

Results

An IMT value > 0.7 mm, cut-off value to define CV risk, was present in 28% of the obese patients and in no T1D patients. Age-adjusted sAGE and HbA1c levels were higher T1D patients, whereas a higher percentage of pathological values was present in most of the remaining studied variables. In T1D patients, there was a higher percentage of females with waist/height ratio > 0.5, LDL cholesterol > 100 mg/dL, triglycerides/HDL cholesterol ratio > 2 and BMI > 99° centile and a higher percentage of males with HbA1c > 7%. On the contrary, in obese patients there were no differences between males and females. Multiple analysis is identified BMI SDS as the only variable with a significant influence on IMT in both groups. Furthermore, it showed that HbA1c and gender affected sAGE in T1D patients, whereas only age and gender in the obese patients.

Conclusions

Our study demonstrates that our adolescents with severe obesity carry a much higher CV risk than adolescents with T1D unless in bad metabolic control. Apart from lower sAGE levels, most of the variables considered to define CV risk were higher in the obese group than in the T1D group. Gender seems to have a significant impact on sAGE levels but not on IMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References.

  1. Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44:129–146

    Article  CAS  Google Scholar 

  2. Basta G, Schmidt AM, De Caterina R (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582–592

    Article  CAS  Google Scholar 

  3. Takeuchi M, Takino JI, Yamagishi SI (2010) Involvement of the toxic AGEs (TAGE) RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy. Curr Drug Target 11:1468–1482

    Article  Google Scholar 

  4. Lind M, Svensson AM, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A (2014) Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 371(21):1972–1982

    Article  CAS  Google Scholar 

  5. Lee EY, Yoon KH (2018) Epidemic obesity in children and adolescents: risk factors and prevention. Front Med 12(6):658–666

    Article  Google Scholar 

  6. NCDRisk Factor Collaboration (NCD-RisC) (2017) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390:2627–2642

    Article  Google Scholar 

  7. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415–1428

    Article  CAS  Google Scholar 

  8. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG et al (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368(9536):666–678

    Article  Google Scholar 

  9. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15–18

    Article  CAS  Google Scholar 

  10. Downie E, Craig ME, Hing S, Cusumano J, Chan AKF, Donaghue KC (2011) Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control. Diabetes Care 34:2368–2373

    Article  CAS  Google Scholar 

  11. Meerwaldt R, Graaff R, Oomen PHN et al (2004) Simple noninvasive assessment of advanced glycation endproduct accumulation. Diabetologia 47(7):1324–1330

    Article  CAS  Google Scholar 

  12. Genevieve M, Vivot A, Gonzalez C et al (2013) Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus. Diabetes Metab 39:349–354

    Article  CAS  Google Scholar 

  13. Conway BN, Aroda VR, Maynard JD, Matter N, Fernandez S, Ratner RE, Orchard TJ (2012) Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes. Diabetes Care 35:2331–2336

    Article  CAS  Google Scholar 

  14. Van Waateringe RP, Slagter SN, van Beek AP et al (2017) Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components. Diabetol Metab Syndr 9(1):42

    Article  CAS  Google Scholar 

  15. Banser A, Naafs JC, Hoorweg-Nijman JJ, van de Garde EM, van der Vorst MM (2016) Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus. Pediatr Diabetes 17(6):426–432

    Article  CAS  Google Scholar 

  16. Van der Heyden JC, Birnie E, Mul D, Bovenberg S, Veeze HJ, Aanstoot HJ (2016) Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study. BMC Endocr Disord 16(1):49

    Article  Google Scholar 

  17. Cho YH, Craig ME, Januszewski AS, Benitez-Aguirre P, Hing S, Jenkins AJ, Donaghue KC (2017) Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications. Diabet Med 34(4):543–550

    Article  CAS  Google Scholar 

  18. Den Engelsen C, van den Donk M, Gorter KJ, Salomé PL, Rutten GE (2012) Advanced glycation end products measured by skin autofluorescence in a population with central obesity. Dermatoendocrinol 4(1):33–38

    Article  CAS  Google Scholar 

  19. Lentferink YE, van Teeseling L, Knibbe CAJ, van der Vorst MMJ (2019) Skin autofluorescence in children with and without obesity. J Pediatr Endocrinol Metab 32(1):41–47

    Article  CAS  Google Scholar 

  20. Järvisalo MJ, Putto-Laurila A, Jartti L, Lehtimäki T, Solakivi T, Rönnemaa T, Raitakari OT (2002) Carotid intima-media thickness in children with type 1 diabetes. Diabetes 51:493–498

    Article  Google Scholar 

  21. Wunsch R, de Sousa G, Toschke AM, Reinehr T (2006) Intima-media thickness in obese children before and after weight loss. Pediatrics 118(6):2334–2340

    Article  Google Scholar 

  22. Park MH, Skow Á, De Matteis S, Kessel AS, Saxena S, Viner RM, Kinra S (2015) Adiposity and carotid-intima media thickness in children and adolescents: a systematic review. BMC Pediatr 16(15):161

    Article  Google Scholar 

  23. Valerio G, Maffeis C, Saggese G, Ambruzzi MA, Balsamo A, Bellone S et al (2018) Diagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics. Ital J Pediatr 44(1):88

    Article  CAS  Google Scholar 

  24. Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, Wühl E, Zanchetti A (2016) 2016 European Society of hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34(10):1887–1920

    Article  CAS  Google Scholar 

  25. Manco M, Grugni G, Di Pietro M, Balsamo A, Di Candia S, Morino GS, Franzese A, Di Bonito P, Maffeis C, Valerio G (2016) Triglycerides-to-HDL cholesterol ratio as screening tool for impaired glucose tolerance in obese children and adolescents. Acta Diabetol 53(3):493–498

    Article  CAS  Google Scholar 

  26. Di Bonito P, Moio N, Scilla C, Cavuto L, Sibilio G, Sanguigno E, Forziato C, Saitta F, Iardino MR, Di Carluccio C, Capaldo B (2012) Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care 35(1):158–162

    Article  CAS  Google Scholar 

  27. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115(4):459–467

    Article  Google Scholar 

  28. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH (1992) Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 327:1350–1355

    Article  CAS  Google Scholar 

  29. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Davey Smith G (1998) Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr 67:1111–1118

    Article  CAS  Google Scholar 

  30. van Waateringe RP, Fokkens BT, Slagter SN, van der Klauw MM, van Vliet-Ostaptchouk JV, Graaff R, Paterson AD, Smit AJ, Lutgers HL, Wolffenbuttel BHR (2019) Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population. Diabetologia 62(2):269–280

    Article  CAS  Google Scholar 

  31. Valerio G, Iafusco D, Zucchini S, Maffeis C (2012) Study-group on diabetes of Italian Society of Pediatric Endocrinology and Diabetology (ISPED). Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 97(1):99–104

    Article  Google Scholar 

  32. Köchli S, Endes K, Trinkler M, Mondoux M, Zahner L, Hanssen H (2019) Association of physical fitness with skin autofluorescence-derived advanced glycation end products in children. Pediatr Res 2

  33. Gill V, Kumar V, Singh K, Kumar A, Kim JJ (2019) Advanced glycation end products (AGEs) may be a striking link between modern diet and health. Biomolecules 9(12):888

    Article  CAS  Google Scholar 

  34. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986

    Article  Google Scholar 

  35. White NH, Sun W, Cleary PA et al (2010) Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 59:1244–1253

    Article  CAS  Google Scholar 

  36. Bancks MP, Ning H, Allen NB, Bertoni AG, Carnethon MR, Correa A, Echouffo-Tcheugui JB, Lange LA, Lloyd-Jones DM, Wilkins JT (2019) Long-term absolute risk for cardiovascular disease stratified by fasting glucose level. Diabetes Care 42(3):457–465

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefano Zucchini.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Managed by Antonio Secchi .

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zucchini, S., Fabi, M., Maltoni, G. et al. Adolescents with severe obesity show a higher cardiovascular (CV) risk than those with type 1 diabetes: a study with skin advanced glycation end products and intima media thickness evaluation. Acta Diabetol 57, 1297–1305 (2020). https://doi.org/10.1007/s00592-020-01537-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-020-01537-1

Keywords

Navigation